Generali Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.41M Sell
17,101
-3,946
-19% -$2.14M 0.18% 115
2025
Q4
$12.2M Buy
21,047
+4,307
+26% +$2.44M 0.25% 88
2025
Q3
$8.12M Buy
16,740
+258
+2% +$120K 0.17% 114
2025
Q2
$6.68M Sell
16,482
-2,586
-14% -$1.08M 0.15% 143
2025
Q1
$9.49M Buy
19,068
+3,385
+22% +$1.83M 0.23% 97
2024
Q4
$8.16M Buy
+15,683
New +$8.62M 0.21% 105

Other funds holding TMO

Generali Asset Management's TMO Position: Q1 2026 in Review

Generali Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 19% in Q1 2026, selling an estimated $2.14M and leaving 17,101 shares worth $8.41M. The position accounts for 0.18% of the portfolio, ranked #115.

Generali Asset Management first reported a position in TMO in Q4 2024 and has held it in 6 quarters since. The position peaked at $12.2M in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Generali Asset Management held 17,101 shares of Thermo Fisher Scientific worth $8.41M as of Q1 2026.
  • Generali Asset Management sold 3,946 Thermo Fisher Scientific shares in Q1 2026, an estimated $2.14M.
  • Thermo Fisher Scientific made up 0.18% of Generali Asset Management's portfolio in Q1 2026, its #115 holding.
  • Generali Asset Management first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 6 quarters since.
  • Generali Asset Management's Thermo Fisher Scientific position peaked at $12.2M in Q4 2025.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Generali Asset Management's 13F filing for Q1 2026, filed 5 May 2026.